Upcoming Medical Conferences in BreckenridgeSearch Criteria : United States of America Breckenridge
Jan 12 - 16, 2019 | Breckenridge, Colorado
Colorado Pharmacists Society (CPS) Winter Meeting is organized by Colorado Pharmacists Society (CPS) and will be held from Jan 12 - 16, 2019 at DoubleTree by Hilton Hotel Breckenridge, Breckenridge, Colorado, United States of America. Additional details will be posted as soon as they are available.
Jan 13 - 17, 2019 | USD $1045 | Breckenridge, Colorado
Single Cell Biology (L1) is organized by Keystone Symposia on Molecular and Cellular Biology and will be held from Jan 13 - 17, 2019 at Beaver Run Resort & Conference Center, Breckenridge, Colorado, United States of America. Course Description : Individual cells are the building blocks of all metazoan organisms, and the importance of analyzing biology at the single cell level has long been recognized. However, only recently have technological developments begun to allow quantitative single cell analyses on a broad scale, leading to an explosion of international single-cell research. This is an interdisciplinary field with fast-developing data acquisition modalities together with bespoke computational approaches, and now is a major driver of progress across many areas of biology, diagnostics and therapy. Dedicated conferences bringing together scientists with different technological, computational and biomedical focus are therefore crucial to ensure mutual communication and to shape future developments. Current single cell meetings focus on high-throughput molecular snapshot measurements and their computational analysis. This conference will go beyond by emphasizing biological and biomedical applications of single cell approaches, including dynamic live cell measurements, to better understand the molecular control of cell fates and multi-cellular tissue generation in health and disease. Plenary Session Topics : • Single Cell Computational Biology • Development at Single Cell Resolution • From Single Cell Measurements to Molecular Mechanisms • Imaging in 3D and in vivo • New Technology for New Biology • Extracting Information from High-Dimensional Measurements • Reconstructing Cell Lineages • Neuroscience at Single Cell Resolution plus two workshops Additional details will be posted as soon as they are available.
Jan 23 - 24, 2019 | CME 16.00 | USD $1450 | Breckenridge, Colorado
2019 UVA Anesthesiology Point-of-Care (PoCUS) Course is organized by University of Virginia (UVA) and will be held from Jan 23 - 24, 2019 at The Village at Breckenridge, Breckenridge, Colorado, United States of America. This CME Conference has been approved for a maximum of 16 AMA PRA Category 1 Credits. The course will be heavily geared towards hands-on learning. The instructor to student ratio will be 1:4 and there will be minimal lecture time in the classroom to maximize time with your hands on the ultrasound probe. Prior to attending the course, participants will be expected to complete online learning in point of care ultrasound, following the flipped classroom model. Course Objectives : At the conclusion of this course, participants should be able to: Basic Cardiac Ultrasound (FATE) • Identify the normal sonographic structures of the heart including atria, ventricles, valves and great vessels • Obtain the 6 basic FATE views including inferior vena cava and pleura • Use M-mode for assessment of cardiac dimensions and function • Recognize common pathology • Recognize rare but life threatening pathology • Use echocardiographic findings to guide clinical decision making • Independently perform and interpret a focused cardiac ultrasound exam Focused Assessment with Sonography for Trauma (FAST) • Identify free fluid in specific anatomic locations • Independently perform and interpret a FAST exam Ultrasound Assessment of Gastric Content • Differentiate qualitatively between empty stomach vs. clear fluid vs. solid • Interpret findings depending on patient position • Assess the risk of aspiration based qualitative findings and quantitative estimations • Independently perform and interpret gastric ultrasound Basic Lung Ultrasound • Choose the appropriate ultrasound system and probe for lung ultrasound imaging • Identify lung and chest wall structures using 2D ultrasound: skin, muscle, intercostal space, pleura, diaphragm • Identify the basic sonographaphic findings of lung ultrasound: A-lines, B-lines, lung sliding, lung point and lung pulse • Use M-mode to identify characteristic air artifacts suggesting normal aeration pattern: “sea-shore sign”, A-lines with lung sliding and lung pulse • Use goal directed lung-ultrasound imaging when evaluating the critical care patient • Independely perform and interpret a point-of-care lung ultrasound exam Additional details will be posted as soon as they are available.
Jan 24 - 26, 2019 | USD $2495 | Breckenridge, Colorado
Musculoskeletal Ultrasound Course is organized by American Osteopathic College of Physical Medicine and Rehabilitation (AOCPMR) and will be held from Jan 24 - 26, 2019 at Beaver Run Resort & Conference Center, Breckenridge, Colorado, United States of America. The target audience for this medical event is physical medicine and rehabilitation clinician currently performing ultrasound imaging or wishing to expand his or her capacity to incorporate ultrasound imaging into the practice. Physicians, residents, and fellows should attend this course. Conference Description: This conference is comprised of two parts: a didactic series and a hands-on skill lab workshop that includes a cadaver session. The lecture topics covered include both fundamental and intermediate topics. This will include discussions on case studies, hydro dissection techniques, ultrasound-guided diagnostic and interventional procedures and dynamic evaluation of shoulder injuries. The focus will be entirely on the shoulder. During the hands-on live portion of the course, participants will be able to perform both diagnostic and interventional ultrasound of the shoulder. Small groups are created based on skill level and groups are kept small to ensure a 1 to 4 faculty to participant ratio. Additional details will be posted as soon as they are available.
Feb 18 - 22, 2019 | USD $1045 | Breckenridge, Colorado
Uncovering Mechanisms of Immune-Based Therapy in Cancer and Autoimmunity (B3) is organized by Keystone Symposia on Molecular and Cellular Biology and will be held from Feb 18 - 22, 2019 at Beaver Run Resort & Conference Center, Breckenridge, Colorado, United States of America. Course Description : Significant progress has been made in the field of immunology over the past two decades. Therapeutic agents such as anti-TNF, anti-CD20, anti-CTLA4, and more recently anti-PD1 have benefited countless patients. This is a unique time for immunologists and clinical scientists to learn from the sheer number of clinical trials assessing immune targets for treatment of cancer and autoimmunity. Currently, there are more than 500 clinical studies testing combinations of checkpoint inhibitors with other pathway antagonists, which will begin to uncover the “immune mechanisms” driving the disease process. This is highlighted by the observation that more than 10-20% of patients treated with anti-PD1 and/or CTLA4 later suffer from autoimmunity (e.g., anti-PD1 treatment is linked to Type 1 diabetes and anti-CTLA-4 linked to IBD). The response rate to cancer treatment is greater in patients with autoimmune predisposition; therefore, the autoimmune side effect is in part associated with patient genetics. Conference topics will include discussions of combination immunotherapies, the genetics of patient response, and strategies to reprogram adaptive and innate immunity, which are key to harnessing the immune system to fight cancer and autoimmune diseases. The symposium will end with a special closing lecture on the future of immunotherapy. Plenary Session Topics: • Checkpoint Blockade Predisposes Patients to Autoimmunity • Genetics of Autoimmunity and Cancer: What Are the Common Denominators? • Cellular Reprogramming: Regulatory vs. Functional Fate • Workshop: Immune Monitoring of Checkpoint Blockade Therapies • Cellular Reprogramming: CD8 T Cell Exhaustion and CD4 T Cell Lineages • Macrophage Biology, Tissue Repair, Autoimmunity and Cancer • Neutrophils and MDSCs in Host Defense and Cancer • Finding the Cure for Cancer • Integrated Themes across Preclinical and Clinical Treatment of Cancer and Autoimmunity Additional details will be posted as soon as they are available.
Mar 03 - 07, 2019 | USD $1045 | Breckenridge, Colorado
Phenotypic Drug Discovery: Recent Advances and Insights from Chemical and Systems Biology (C1) is organized by Keystone Symposia on Molecular and Cellular Biology and will be held from Mar 03 - 07, 2019 at Beaver Run Resort & Conference Center, Breckenridge, Colorado, United States of America. Course Description : Unlike conventional target-centric drug discovery, Phenotypic Drug Discovery (PDD) places its focus on disease-relevant phenotypes and agnosticism with regard to molecular mechanism of action. The unique opportunities it offers in terms of discovery of novel biology and first-in-class therapeutics are matched with significant challenges, a number of which can be addressed by recent advances in chemical and systems biology. A key aspect of the meeting will be to share information/processes on how best to employ phenotypic strategies to discover novel biology and effectively prosecute drug discovery programs. Specific topics will include: Chemical biology advances and case studies in Target Identification; Case studies of recently advanced clinical candidates and approved drugs; Functional genomics and systems biology advances and case studies; Project prosecution: lessons learned from lead optimization and pre-clinical development; Complex cell-based models and new assay modalities. With few non-commercial meetings covering drug discovery as a discipline, this conference has the stature and breadth to bring together accomplished and influential scientists from industry and academia as demonstrated by the 2016 edition. Its scope will be broader than other PDD and Chemical Biology meetings since it will cover the entire range of activities and technologies from phenotypic assay systems, to target identification and FDA approval of novel therapeutics. Given that there is still an emphasis on target centric discovery in pharmaceutical companies – this meeting can be instrumental in further promoting a shift in mindset and contributing to the consolidation of PDD as an integral part of the drug discovery paradigm. The vision for this conference would be to share success stories - newly approved drugs and late stage clinical candidates - along with key lessons and best practices to inform future PDD projects. Additional details will be posted as soon as they are available.
Apr 07 - 11, 2019 | USD $1045 | Breckenridge, Colorado
Antibodies as Drugs: New Horizons in the Therapeutic Use of Engineered Antibodies (D2) is organized by Keystone Symposia on Molecular and Cellular Biology and will be held from Apr 07 - 11, 2019 at Beaver Run Resort & Conference Center, Breckenridge, Colorado, United States Of America. Course Description : Over the last twenty years recombinant antibodies have been established into clinical practice for the treatment of diseases ranging from cancer, to autoimmune and infectious diseases. While the first approved antibodies were native IgG antibodies, in recent years the field has rapidly advanced and therapeutic antibodies in preclinical and clinical development now include many non-canonical formats including Fc- engineered antibodies, antibody drug conjugates, bispecific antibodies and antibody-like scaffolds. This Keystone conference “Antibodies as Drugs: New horizons in the therapeutic use of engineered antibodies” aims to bring together experts in antibody therapeutics, engineering and mechanisms of action from industry and academia to discuss and review the state-of-the-art in the field and discuss their future potential. The meeting aims to foster cross-fertilization between different engineering technologies and scientists from different therapeutic areas. It also aims to initiate collaboration on the development of state-of-the-art antibody therapies with the aim to improve therapeutic options for patients. For participants in training this meeting will be an opportunity to gain insight into various aspects of therapeutic antibodies and to discuss their projects and ideas face-to-face with experts in the field. In order to differentiate the meeting from more commercial meetings in the field there will be a focus on the inclusion of novel/unpublished data. The meeting will be co-located with the Keystone conference “B Cell Repertoire: From Genetics to Treatment” to benefit from novel discoveries in B cell biology and the discovery of patient derived antibodies. Additional details will be posted as soon as they are available.
Nov 19, 2018 - Apr 12, 2019 | CME 20.00 | Breckenridge, Colorado
AEI - The 2018-19 Medical-Dental-Legal Update is organized by American Educational Institute (AEI) and will be held weekly from Nov 19, 2018 - Apr 12, 2019 at Beaver Run Resort & Conference Center, Breckenridge, Colorado, United States of America. The target audience for this medical event is Physicians, Dentist and other Healthcare Professionals. This CME Conference has been approved for a maximum of 20 AMA PRA Category 1 Credits, 20 ABIM MOC, 16.75 AAFP Credits, 20 AOA Category 2-B Credits. Conference Description: You practice in a dynamic and challenging environment. While keeping clinically current is imperative, it isn't enough. You must also acquire the skills necessary to navigate a professional liability minefield, manage a more effective and efficient practice, and navigate a maze of healthcare laws and regulations. The 2018–19 Medical-Dental-Legal Update Update is designed to assist you in that endeavor. The course, offered weekly in 32 enviable destinations, is a unique, 20-hour survey of the intersection of medicine and law as well as selected clinical topics. Produced in state-of-the-art production studios with broadcast-grade, HD digital technology. Conference Objectives are: • Understand and avoid malpractice litigation. • Identify and reduce healthcare office risk. • Understand and start a direct patient care practice. • Protect professional and personal assets. • Utilize non-pharmacologic techniques for managing chronic stress. • Utilize a variety of clinically relevant but relatively unknown treatments. • Consult patients on the benefits of a longevity diet. • Utilize aspirin as a primary prevention agent for CVD, stroke and colon cancer. • Understand risks and benefits of cannabis and cannabinoids in pain management. • Understand and utilize common imaging modalities and techniques. • Identify and avoid legal and ethical pitfalls of treating unreasonable patients. • Implement new type 2 diabetes practice guidelines aimed at cardiovascular risk reduction. • Interpret chest X-rays for common clinical conditions. • Improve practice profitability through more efficient patient flow. • Reduce professional financial stress by better benefit planning. • Understand and reduce medication nonadherence. • Understand Alzheimer’s disease and better interact with afflicted patients. • Understand and manage malpractice litigation stress. • Incorporate the relationship between diabetes and oral health into patient care. Meetings Dates: Every Week, Monday - Friday 7:30 - 9:30 am. & 4:00 - 6:00 pm Additional details will be posted as soon as they are available.